Browse by author
Lookup NU author(s): Professor Ian McKeith, Dr Urs Mosimann
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Lewy bodies (LB) in the central nervous system are associated with several different clinical syndromes including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Long term follow up of PD patients finds up to 78% eventually develop dementia, most of these patients exhibiting fluctuating cognition and visual hallucinations similar to DLB and with extensive cortical LB at autopsy. alpha-Synuclein positive, neuritic pathology, in the putamen of DLB and Parkinson's disease dementia (PDD), may contribute to postural-instability gait difficulty, parkinsonism, diminished levodopa responsiveness and increased neuroleptic sensitivity. Cognitive and neuropsychiatric symptoms improve with cholinesterase inhibitor treatment in both patient groups. DLB and PDD should be seen as different points on a spectrum of LB disease. Distinguishing them as separate disorders may be useful in clinical practice, but may be of limited value in terms of investigating and treating the underlying neurobiology. (C) 2004 Elsevier Ltd. All rights reserved.
Author(s): McKeith IG, Mosimann UP
Publication type: Conference Proceedings (inc. Abstract)
Publication status: Published
Conference Name: 8th International Symposium on the Treatment of Parkinsons Disease
Year of Conference: 2004
Pages: S15-S18
ISSN: 1353-8020
Publisher: Parkinsonism & Related Disorders: Elsevier
URL: http://dx.doi.org/10.1016/j.parkreldis.2003.12.005
DOI: 10.1016/j.parkreldis.2003.12.005
Library holdings: Search Newcastle University Library for this item
ISBN: